Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)

CAPS Rating: 5 out of 5

A biopharmaceutical company that acquires and advances a diversified portfolio of drug candidates, with a focus on oncology, urology and other critical health challenges for which there are few other treatment options.

Recs

0
Player Avatar TMFBiologyFool (98.28) Submitted: 1/24/2012 2:33:16 PM : Outperform Start Price: $13.49 SPPI Score: -14.46

Zevalin is the key

Featured Broker Partners


Advertisement